Raleigh Capital Management’s STAAR Surgical STAA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-65
Closed -$3.15K 901
2022
Q4
$3.15K Buy
65
+34
+110% +$2.13K ﹤0.01% 623
2022
Q3
$2K Buy
+31
New +$2.65K ﹤0.01% 681

Other funds holding STAA

Raleigh Capital Management's STAA Position: Q1 2023 in Review

Raleigh Capital Management sold out of STAAR Surgical (STAA) in Q1 2023, closing a stake of 65 shares — an estimated $3.15K sold.

Raleigh Capital Management first reported a position in STAA in Q3 2022 and held it in 2 quarters. The position peaked at $3.15K in Q4 2022. 251 funds tracked by Wall St. Rank hold STAA as of Q1 2023.

  • Raleigh Capital Management reported no remaining STAAR Surgical position as of Q1 2023 after selling out during the quarter.
  • Raleigh Capital Management sold 65 STAAR Surgical shares in Q1 2023, an estimated $3.15K.
  • Raleigh Capital Management first reported a position in STAAR Surgical in Q3 2022 and held it in 2 quarters.
  • Raleigh Capital Management's STAAR Surgical position peaked at $3.15K in Q4 2022.
  • 251 funds tracked by Wall St. Rank held STAAR Surgical as of Q1 2023.

Based on Raleigh Capital Management's 13F filing for Q1 2023, filed 22 May 2023.